Theranostics, An Issue of PET Clinics
- 1 Edición, Volumen 21-3 - 5 de junio de 2026
- Última edición
- Editores: Harshad Kulkarni, Abass Alavi
- Idioma: Inglés
In this issue of PET Clinics, guest editors Drs. Harshad Kulkarni and Abass Alavi bring their considerable expertise to the topic of Theranostics. Tops experts cover key topics su… Leer más
Descripción
Descripción
In this issue of PET Clinics, guest editors Drs. Harshad Kulkarni and Abass Alavi bring their considerable expertise to the topic of Theranostics. Tops experts cover key topics such as total-body PET in theranostics: transforming treatment planning and follow-up; FAP-targeted imaging and therapy; theranostics in neuroendocrine neoplasms: integrating imaging, therapy, and dosimetry; theranostics: when targeting imaging leads to a targeted therapy; and much more.
Puntos claves
Puntos claves
- Contains 15 relevant, practice-oriented topics including PSMA theranostics in prostate cancer; AI and quantification in theranostics: enabling response prediction and dosimetric accuracy; theranostics in pediatric oncology; building sustainable theranostics programs; PET-based radiation therapy; state-of-the-art radioiodine theranostics of thyroid cancer; and more
- Provides in-depth clinical reviews on theranostics, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
De interès para
De interès para
Radiology, nuclear medicine
Índice
Índice
Theranostics in Nuclear Medicine: Historical, Regulatory, and Evidence Context for the Practicing Nuclear Medicine Physician
Total-Body PET in Theranostics: Reshaping Treatment Planning and Follow-Up
State-of-the-Art Theranostics of Thyroid Cancer
Theranostics in Neuroendocrine Neoplasms: The Multifaceted Aspects Integrating Imaging, Therapy, and Dosimetry
Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer – Current State and Evolving Standards
Artificial Intelligence Across the PSMA Theranostic Continuum in Prostate Cancer
Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen
Fibroblast Activation Protein: Molecular Imaging and Beyond
Theranostics: When Targeted Imaging Guides Targeted Therapy
Role of PET in Radiation Oncology: A Theranostic Perspective on Detection of Radiation- Induced Complications
Building Sustainable Theranostics Programs: Operational Models, Access, and Equity
Total-Body PET in Theranostics: Reshaping Treatment Planning and Follow-Up
State-of-the-Art Theranostics of Thyroid Cancer
Theranostics in Neuroendocrine Neoplasms: The Multifaceted Aspects Integrating Imaging, Therapy, and Dosimetry
Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer – Current State and Evolving Standards
Artificial Intelligence Across the PSMA Theranostic Continuum in Prostate Cancer
Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen
Fibroblast Activation Protein: Molecular Imaging and Beyond
Theranostics: When Targeted Imaging Guides Targeted Therapy
Role of PET in Radiation Oncology: A Theranostic Perspective on Detection of Radiation- Induced Complications
Building Sustainable Theranostics Programs: Operational Models, Access, and Equity
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 21-3
- Publicado: 5 de junio de 2026
- Idioma: Inglés
Sobre los editores
Sobre los editores
Harshad Kulkarni
Editor
Afiliaciones y experiencia
Chief Medical Advisory, BAMF Health, Grand Rapid, Michigan, USAAbass Alavi
Editor
Afiliaciones y experiencia
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA